The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Surquin, M.
Right arrow Articles by Abramowicz, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Surquin, M.
Right arrow Articles by Abramowicz, D.
The Journal of Immunology, 2002, 169: 500-506.
Copyright © 2002 by The American Association of Immunologists

Skin Graft Rejection Elicited by {beta}2-Microglobulin as a Minor Transplantation Antigen Involves Multiple Effector Pathways: Role of Fas-Fas Ligand Interactions and Th2-Dependent Graft Eosinophil Infiltrates1

Murielle Surquin2,*,{dagger}, Alain Le Moine*,{dagger}, Véronique Flamand*, Nathalie Nagy{ddagger}, Katia Rombaut{ddagger}, François-Xavier Demoor*, Patrick Stordeur*, Isabelle Salmon{ddagger}, Jean-Charles Guéry§, Michel Goldman* and Daniel Abramowicz{dagger}

* Laboratory of Experimental Immunology, Université Libre de Bruxelles, and Departments of {dagger} Nephrology and {ddagger} Pathology, Hôpital Erasme, Brussels, Belgium; and § Institut National de la Santé et de la Recherche Médicale, Unité 28, Hôpital Purpan, Toulouse, France

{beta}2-Microglobulin ({beta}2m)-derived peptides are minor transplantation Ags in mice as {beta}2m-positive skin grafts ({beta}2m+/+) are rejected by genetically {beta}2m-deficient recipient mice ({beta}2m-/-). We studied the effector pathways responsible for the rejection induced by {beta}2-microglobulin-derived minor transplantation Ags. The rejection of {beta}2m+/+ skin grafts by naive {beta}2m-/- mice was dependent on both CD4 and CD8 T cells as shown by administration of depleting mAbs. Experiments performed with {beta}2m-/-CD8-/- double knockout mice grafted with a {beta}2m+/+ MHC class I-deficient skin showed that sensitized CD4 T cells directed at {beta}2m peptides-MHC class II complexes are sufficient to trigger rapid rejection. Rejection of {beta}2m+/+ grafts was associated with the production of IL-5 in vitro, the expression of IL-4 and IL-5 mRNAs in the grafted tissue, and the presence within rejected grafts of a considerable eosinophil infiltrate. Blocking IL-4 and IL-5 in vivo and depleting eosinophils with an anti-CCR3 mAb prevented graft eosinophil infiltration and prolonged {beta}2m+/+ skin graft survival. Lymphocytes from rejecting {beta}2m-/- mice also displayed an increased production of IFN-{gamma} after culture with {beta}2m+/+ minor alloantigens. In vivo neutralization of IFN-{gamma} inhibited skin graft rejection. Finally, {beta}2m+/+ skin grafts harvested from B6lpr/lpr donor mice, which lack a functional Fas molecule, survived longer than wild-type {beta}2m+/+ skin grafts, showing that Fas-Fas ligand interactions are involved in the rejection process. We conclude that IL-4- and IL-5-dependent eosinophilic rejection, IFN-{gamma}-dependent mechanisms, and Fas-Fas ligand interactions are effector pathways in the acute rejection of minor transplantation Ags.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. He, S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger
Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice
J. Immunol., January 1, 2004; 172(1): 240 - 247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.